Global Transdermal Contraceptive Patch Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Contraceptive Patch Market Research Report 2024
A transdermal contraceptive patch, often simply referred to as a contraceptive patch, is a birth control method that provides hormonal contraception through the skin. It is a convenient and reversible form of contraception for people who prefer not to take oral contraceptive pills or use other birth control methods.
How it WorksThe transdermal contraceptive patch is designed to release hormones into the body through the skin. It typically contains two synthetic hormonesestrogen and progestin.
Using a transdermal contraceptive patch typically involves the following steps
PlacementThe patch is a small, adhesive square or rectangle that is applied directly to the skin. It is usually placed on the buttocks, abdomen, upper torso, or outer arm. It should not be applied to the breasts or any area with cuts, irritation, or lotions.
Change ScheduleDepending on the specific brand and type of patch, it needs to be changed once a week for three weeks in a row, followed by a one-week patch-free period.
Cycle ContinuationAfter the patch-free week, a new cycle begins with the application of a fresh patch. This cycle continues as long as contraception is desired.
According to Mr Accuracy reports’s new survey, global Transdermal Contraceptive Patch market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Transdermal Contraceptive Patch market research.
Key manufacturers engaged in the Transdermal Contraceptive Patch industry include Gedeon Richter, Mylan Pharmaceuticals, Twirla, Luye Pharma and AbbVie, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Transdermal Contraceptive Patch were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Transdermal Contraceptive Patch market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Contraceptive Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Gedeon Richter
Mylan Pharmaceuticals
Twirla
Luye Pharma
AbbVie
Segment by Type
Seven Days Replacement
Three Days Replacement
Online Sales
Offline Sales
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Transdermal Contraceptive Patch report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
How it WorksThe transdermal contraceptive patch is designed to release hormones into the body through the skin. It typically contains two synthetic hormonesestrogen and progestin.
Using a transdermal contraceptive patch typically involves the following steps
PlacementThe patch is a small, adhesive square or rectangle that is applied directly to the skin. It is usually placed on the buttocks, abdomen, upper torso, or outer arm. It should not be applied to the breasts or any area with cuts, irritation, or lotions.
Change ScheduleDepending on the specific brand and type of patch, it needs to be changed once a week for three weeks in a row, followed by a one-week patch-free period.
Cycle ContinuationAfter the patch-free week, a new cycle begins with the application of a fresh patch. This cycle continues as long as contraception is desired.
According to Mr Accuracy reports’s new survey, global Transdermal Contraceptive Patch market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Transdermal Contraceptive Patch market research.
Key manufacturers engaged in the Transdermal Contraceptive Patch industry include Gedeon Richter, Mylan Pharmaceuticals, Twirla, Luye Pharma and AbbVie, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2022.
When refers to consumption region, % volume of Transdermal Contraceptive Patch were sold to North America, Europe and Asia Pacific in 2022. Moreover, China, plays a key role in the whole Transdermal Contraceptive Patch market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Contraceptive Patch market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gedeon Richter
Mylan Pharmaceuticals
Twirla
Luye Pharma
AbbVie
Segment by Type
Seven Days Replacement
Three Days Replacement
Segment by Application
Online Sales
Offline Sales
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Transdermal Contraceptive Patch report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices